More Business Wire
View Older Stories View Newer Stories-
Natera CEO Steve Chapman Recognized as a 2024 Top Healthcare Technology CEO and BioTechnology Innovator of the Year
-
The Southern Group Expands to Washington, D.C. With Strategic Federal Lobbying Practice “TSG Advocates” Led by Daniel Diaz-Balart and Chase Kroll
-
RBC Bearings to Webcast Third Quarter Fiscal Year 2025 Earnings Conference Call January 31st
-
Qualcomm Announces Quarterly Cash Dividend
-
Studiobside Unveils First Look at Upcoming Game, 'StarSavior', with New PV
-
Sakrete and Amerimix Host Immersive World of Concrete Experience
-
Boston Omaha Corporation Announces Appointment of David S. Graff to Board of Directors
-
Oklo and RPower Join Forces to Accelerate Power Availability for Data Centers
-
BTIG to Donate $1 Million to Los Angeles Wildfire Recovery Efforts
-
The Bancorp, Inc. Sets Fourth Quarter and Fiscal 2024 Financial Results Release Date and Conference Call
-
Benefit Street Partners L.L.C. Announces Closing of a $135 Million Loan Package on The Empire Hotel
-
ServiceNow Accelerates Agentic AI Roadmap With Acquisition of AI Native Conversation Data Analysis Platform Cuein
-
AlTi Global, Inc. to Participate in Upcoming UBS Financial Services Conference and BofA Securities US Financial Services Conference
-
Bumble Inc. Announces Leadership Transition to Drive its Next Phase of Transformation
-
Arcos Dorados Announces Proposed Offering of Senior Notes
-
ImmunoPrecise Antibodies Realigns Pipeline Strategy, Empowering Drug Discovery with AI and First-Principles Innovation
-
Cookies and Green Monké Bring New THC-Infused Drinks to Ten US States
-
Kay Cossington, MBE, to Launch Bay Collective, A Multi-Club Women’s Football Organization in Partnership with Sixth Street
-
Jefferies Clients, Shareholders and Employees Contribute $10 Million to Charities Supporting Los Angeles Wildfire Relief
-
KB Home Announces the Grand Opening of Its Newest Community in Robla, a Prime Sacramento Neighborhood
-
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Southlake Financial Group Expands Footprint with Acquisition of Nevada General Insurance Company
-
Boundless Learning™ Appoints Joshua Richards as Chief Executive Officer
-
Cynet Adds Leaders to Advance Channel Strategy
-
Pending Home Sales Fell the Most Since 2022 in December as Mortgage Rates Jumped
-
Franklin Templeton Closed-End Funds Announce Share Repurchases for the Fourth Quarter of 2024
-
United Rentals Names Julie Brandt to Board of Directors
-
Tanger Declares Dividend Payable February 14, 2025
-
KB Home Announces the Grand Opening of Its Newest Community in Popular Lake Stevens, Washington
-
WorldQuant Foundry Appoints Dr. Christopher Mason as Senior Healthcare Advisor to Spearhead AI-Driven Healthcare Innovation
-
Jessica Skon, President and CEO of BTS Group, named a Top 25 Consulting Firm CEOs of 2024
-
OFS Credit Company Declares Monthly Common Stock Cash Distributions
-
WisdomTree Schedules Earnings Conference Call for Q4 on January 31, 2025 at 11:00 a.m. ET
-
Terra Firma Energy Limited Announces Commercial Operation at Droitwich Flexible Generation Site
-
Webster Reports Fourth Quarter 2024 EPS of $1.01; Adjusted EPS of $1.43
-
Zai Lab Announces Acceptance of New Drug Application for KarXT for the Treatment of Schizophrenia
-
Realbotix to Release its Financial Results for Year End-2024 on January 28, 2025
-
Ouster Announces Departure of Chief Financial Officer and Reaffirms Q4 Revenue Guidance
-
State Street Corporation (NYSE: STT) Reports Fourth-Quarter and Full-Year 2024 Financial Results
-
NAMSA Acquires the U.S. Medical Device Testing Operations of WuXi AppTec, Solidifying its Position as the Leader in MedTech Testing and Clinical Research
-
Silver Storm Closes Third Tranche of Its Non-Brokered Private Placement Offering Including Participation by Eric Sprott, and Engagement of Whittle Consulting
-
U.S. Food and Drug Administration Approves FoundationOne®CDx as a Companion Diagnostic for OJEMDA™ (tovorafenib) to Treat the Most Common Form of Childhood Brain Tumor in Pediatric Patients
-
CALQUENCE® (acalabrutinib) plus chemoimmunotherapy approved in the US for patients with previously untreated mantle cell lymphoma
-
Walmart Unveils New 350-Acre Campus in Bentonville
-
Craig Melvin and Savannah Guthrie Reveal How Their Friendship Began in Parade’s Exclusive Cover Story: ‘We Don’t Have to Fake It’
-
GCT Semiconductor Participates in Exclusive Aramco Digital and 450 MHz Alliance Event on Innovations in Private Networks
-
Castle’s Poster on DecisionDx®-SCC Selected as a “Late Breakers” Top Five Finalist for the Akamai Award, Recognizing the Best Posters at Maui Derm Hawaii 2025
-
Virtus Investment Partners to Announce Fourth Quarter 2024 Results on Friday, January 31
-
Twilio to Announce Fourth Quarter and Fiscal Year 2024 Results on February 13, 2025
-
Exchange Income Corporation Announces January 2025 Dividend
